JFMC33-0502_2A | R Documentation |
Kaplan-Meier digitized data from JFMC33-0502, figure 2A (PMID 26347106). A reported sample size of 1,071 for a primary endpoint of DFS in colorectal cancer.
`JFMC33-0502_2A`
A data frame of 1,060 observations and 3 variables:
time | event time (in years) | |
event | DFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (control, study) | |
Sadahiro S, Tsuchiya T, Sasaki K, et al. Randomized phase III trial of treatment duration for oral uracil and tegafur plus leucovorin as adjuvant chemotherapy for patients with stage IIB/III colon cancer: final results of JFMC33-0502. Ann Oncol 2015; 26: 2274–80.
summary(`JFMC33-0502_2A`)
kmplot(`JFMC33-0502_2A`)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.